1.Effects of ethyl acetate extract of Semen Hoveniae on liver microsomal cytochrome P450 isoenzyme in rat.
Hong ZHANG ; Juan SONG ; Xin-An ZHAN ; Ye TAN
China Journal of Chinese Materia Medica 2007;32(18):1917-1921
<p>OBJECTIVETo investigate the effects of the ethyl acetate extract of Semen Hoveniae (ESH) on liver microsomal cytochrome P450 isoenzyme in rats.p><p>METHODThe rats were given orally the ESH in the doses of 0.14, 0.17, 0.2 g x kg (equivalent to the crude herb) for 10 days respectively. Rat liver microsomal cytochrome P450, NADPH-Cyt C reductase, erythromycin N-demethylase (ERD), Aniline hydroxylase (ANH), aminopyrine N-demethylase (ADM) activities were quantitated by UV chromatography. The levels of mRNA expression of CYP1A1, CYP2C11, CYP2E1 and CYP3A1 were detected by semi-quantitative reverse transcripatase-polymerase chain reaction (RT-PCR).p><p>RESULTThe cytochrome P450 content, NADPH-Cyt C reductase activities and erythromycin N-demethylase (ERD) activities were not affected. Aniline hydroxylase (ANH) activities in liver were decreased by up to35.1%; aminopyrine N-demethylase (ADM) activitiesin liver were increased by up to 42.4%. The mRNA expression of CYP1A1, CYP2C11 and CYP3A1 were found to be increased markedly.p><p>CONCLUSIONA specific effect of ESH on liver microsomal cytochrome P450 isoenzyme in rats was observed in this investigation. ESH had various effects on liver microsomal cytochrome P450 isoenzyme.p>
Acetates
;
chemistry
;
Aminopyrine N-Demethylase
;
metabolism
;
Aniline Hydroxylase
;
genetics
;
metabolism
;
Animals
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Cytochrome P450 Family 2
;
Drugs, Chinese Herbal
;
chemistry
;
isolation & purification
;
pharmacology
;
Gene Expression Regulation, Enzymologic
;
drug effects
;
Male
;
Microsomes, Liver
;
drug effects
;
enzymology
;
NADPH-Ferrihemoprotein Reductase
;
genetics
;
metabolism
;
Plants, Medicinal
;
chemistry
;
RNA, Messenger
;
genetics
;
metabolism
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Reverse Transcriptase Polymerase Chain Reaction
;
Rhamnaceae
;
chemistry
;
Seeds
;
chemistry
;
Steroid 16-alpha-Hydroxylase
;
genetics
;
metabolism
2.Effects of Schisandra chinensis (Wuweizi) constituents on the activity of hepatic microsomal CYP450 isozymes in rats detected by using a cocktail probe substrates method.
Bao-Lian WANG ; Jin-Ping HU ; Li SHENG ; Yan LI
Acta Pharmaceutica Sinica 2011;46(8):922-927
Effects of constituents from Schisandra chinensis (Wuweizi) on six liver microsomal CYP450 isozymes (CYP1A2, CYP2C6, CYP2C11, CYP2D2, CYP2E1 and CYP3A1/2) were studied in rats in vivo and in vitro. The in vitro incubation was conducted using liver microsomes of rats after multiple dosing of alcoholic/water extract from Schisandra chinensis. A HPLC-MS method was applied to determine the metabolites formation of six CYP450s probe substrates (phenacetin-CYP1A2, dextromethorphan-CYP2D2, diclofenac sodium-CYP2C6, mephenytoin-CYP2C11, chlorzoxazone-CYP2E1 and midazolam-CYP3A1/2) in rat liver microsomal incubations. The activity of CYP450 isozymes were represented by the formation of metabolites. Alcoholic extract of Schisandra chinensis (28-120 microg x mL(-1)) showed significant inhibitory effect on six CYP450 isozymes to a certain extent in vitro. Multiple dosing of Schisandra chinensis alcoholic extract (1.5 g x kg(-1), qd x 7d) had significant induction on CYP2E1 and CYP3A1/2, inhibition on CYP2D2 and CYP2C11, and no effect on CYP2C6 and CYP1A2. Water extract of Schisandra chinensis (100-500 microg x mL(-1)) also exhibited inhibition on the activity of CYP450 isozymes in vitro, whereas multiple administrations (1.5 g x kg(-1), qd x 7d) had significant induction of CYP2E1 and inhibition on CYP2D2, no effect on CYP2C6, CYP3A1/2, CYP1A2 or CYP2C11. The results suggested that the constituents from Schisandra chinensis exhibited the inhibition and induction on six rat liver microsomal CYP450 isozymes to a certain extent in vivo and in vitro. The possibility of interaction between Schisandra chinensis and coadministrative drugs will be considered base on the levels and subtype of CYP450 involved in the drug metabolism.
Animals
;
Aryl Hydrocarbon Hydroxylases
;
metabolism
;
Cytochrome P-450 CYP1A2
;
metabolism
;
Cytochrome P-450 CYP2E1
;
metabolism
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Cytochrome P450 Family 2
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
Isoenzymes
;
metabolism
;
Lignans
;
isolation & purification
;
pharmacology
;
Microsomes, Liver
;
enzymology
;
Plants, Medicinal
;
chemistry
;
Rats
;
Rats, Sprague-Dawley
;
Schisandra
;
chemistry
;
Steroid 16-alpha-Hydroxylase
;
metabolism
;
Steroid 21-Hydroxylase
;
metabolism
;
Substrate Specificity
3.Effect of shenfu injection on CYP450s of rat liver.
Han LI ; Yu-Guang WANG ; Zeng-Chun MA ; Si-Si ZHOU ; Qian-De LIANG ; Cheng-Rong XIAO ; Hong-Ling TAN ; Xiang-Lin TANG ; Hua LI ; Guo-Lin SHEN ; Bo-Li ZHANG ; Yue GAO
Acta Pharmaceutica Sinica 2013;48(5):728-733
The paper is to report the study of the effect of Shenfu injection on the enzyme activity of liver CYP450 and its mRNA level of rat liver. Microsome of rat liver was prepared after intravenous administration of Shenfu injection for 7 days. The enzyme activity was quantified by Cocktail method. Meanwhile, the mRNA expression of CYP1A2, CYP2B1/2, CYP2C11 and CYP3A1 in the liver was detected by RT-PCR. Shenfu injection obviously induced the enzyme activities of CYP2B and CYP2C. Meantime Shenfu injection decreased the enzyme activities of CYP1A2 and CYP3A. The mRNA levels of CYP2B and CYP2C were also induced in rats treated with Shenfu injection. But it obviously inhibited the mRNA level of CYP1A2 and CYP3A. Since the enzyme activity and mRNA level were obviously changed after administration, the potential effect of drug-drug interaction should be concerned.
Aconitum
;
chemistry
;
Animals
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A2
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2B1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Cytochrome P450 Family 2
;
Drug Combinations
;
Drugs, Chinese Herbal
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Injections
;
Male
;
Microsomes, Liver
;
enzymology
;
Panax
;
chemistry
;
Plants, Medicinal
;
chemistry
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Steroid 16-alpha-Hydroxylase
;
genetics
;
metabolism
4.Effects of bicyclol on the activity and expression of CYP450 enzymes of rats after partial hepatectomy.
Xiao-Min YAO ; Bao-Lian WANG ; Yu GU ; Yan LI
Acta Pharmaceutica Sinica 2011;46(6):656-663
The present study was performed to investigate the effect of bicyclol on hepatic microsomal cytochrome P450 (CYP) activity, as well as gene and protein expressions in rats after partial hepatectomy (PH). Bicyclol (300 mg x kg(-1)) was given to rats subjected to 70% hepatectomy three times before operation. At 6 and 48 h after PH, blood and liver tissue samples were collected for the measurement of serum alanine aminotransferase (ALT), hepatic microsomal malondialdehyde (MDA) and total hepatic CYP content. The activities of four CYP isozymes were detected with liquid chromatography-mass spectrometry (LC-MS) and the gene and protein expressions were determined by RT-PCR and Western blotting assay. As a result, bicyclol pretreatment markedly inhibited the elevation of serum ALT and hepatic microsomal MDA, and prevented the decrease of total hepatic CYP content in PH rats. In addition, bicyclol significantly attenuated the reduction of CYP2C6 activity and mRNA expression, as well as the reduction of CYP2C11 activity in PH rats. Bicyclol can inhibit the decrease of CYP3A1/2 activity, and up-regulate the mRNA and protein expressions of CYP3A1 and CYP2E1. These results showed that bicyclol pretreatment might ameliorate abnormality in CYP450 isoforms during liver regeneration after PH, and this protective effect was likely due to its anti-oxidative property and enzyme induction.
Alanine Transaminase
;
blood
;
Animals
;
Antioxidants
;
pharmacology
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
metabolism
;
Biphenyl Compounds
;
pharmacology
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Cytochrome P450 Family 2
;
Enzyme Activation
;
drug effects
;
Enzyme Induction
;
drug effects
;
Hepatectomy
;
Male
;
Malondialdehyde
;
metabolism
;
Membrane Proteins
;
genetics
;
metabolism
;
Microsomes, Liver
;
metabolism
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Steroid 16-alpha-Hydroxylase
;
genetics
;
metabolism
;
Steroid 21-Hydroxylase
;
genetics
;
metabolism
5.Effects of brucine combined with glycyrrhetinic acid or liquiritin on rat hepatic cytochrome P450 activities in vivo.
Pan-pan XING ; Wen-hua WU ; Peng DU ; Feng-mei HAN ; Yong CHEN
Acta Pharmaceutica Sinica 2011;46(5):573-580
Abstract: The activities of four CYP450 enzymes (CYP3A, 1A2, 2El and 2C) and the mRNA expression levels of CYP1A2, 2El, 2Cll and 3A1 in rat liver were determined after Wistar rats were orally administered with brucine (BR) at three dosage levels (3, 15 and 60 mg.kg-1 per day) and the high dose of BR combined with glycyrrhetinic acid (GA, 25 mg.kg-1 per day) or liquiritin (LQ, 20 mg.kg-1 per day) for 7 consecutive days. Compared with the control, brucine caused 24.5% and 34.6% decrease of CYP3A-associated testosterone 6beta-hydroxylation (6betaTesto-OH) and CYP2C-associated tolbutamide hydroxylation (Tol-OH), respectively, and 146.1% increase of CYP2El-associated para-nitrophenol hydroxylation (PNP-OH) at the high dose level. On the other hand, (BR+GA) caused 51.4% and 33.5% decrease, respectively, of CYP2El-associated PNP-OH and CYP1A2-associated ethoxyresorufin-O-de-ethylation (EROD) as compared with the high dose of BR group. Meanwhile, (BR+LQ) caused 41.1% decrease of CYP2El-associated PNP-OH and 37.7% increase of CYP2C-associated Tol-OH. The results indicated that the co-administration of BR with GA or LQ had effect on mRNA expression and activities of the CYP450 enzymes mentioned above to some extent, and the in vivo antagonism of LQ on BR-induced CYPs adverse effects and the in vivo inhibitory action of GA on CYP2E1 and 1A2 might play an important role in the detoxification of Radix Glycyrrhizae against Strychnos nux-vomica L.
Animals
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A1
;
metabolism
;
Cytochrome P-450 CYP1A2
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Cytochrome P450 Family 2
;
Flavanones
;
pharmacology
;
Gene Expression Regulation, Enzymologic
;
Glucosides
;
pharmacology
;
Glycyrrhetinic Acid
;
pharmacology
;
Hydroxylation
;
Liver
;
enzymology
;
metabolism
;
Male
;
Nitrophenols
;
metabolism
;
Plants, Medicinal
;
chemistry
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Wistar
;
Steroid 16-alpha-Hydroxylase
;
genetics
;
metabolism
;
Steroid Hydroxylases
;
metabolism
;
Strychnine
;
analogs & derivatives
;
isolation & purification
;
pharmacology
;
Strychnos nux-vomica
;
chemistry
;
Tolbutamide
;
metabolism
6.Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs.
Qiang LI ; Hai-Hua HUANG ; Yu DONG ; Da-Fang ZHONG
Acta Pharmaceutica Sinica 2005;40(10):912-915
<p>AIMTo identify the drug-metabolizing enzymes involved in the hydroxylation of the new anti-inflammatory and anodyne imrecoxib.p><p>METHODSImrecoxib was incubated with heterologous expression human cytochrome P450 (rCYPs) in vitro, and metabolites and remained parent drug were detected with liquid chromatography-multistage mass spectrometry. The contribution of 4 CYPs in the hydroxylation metabolism of imrecoxib was evaluated by total normalized rate (TNR) method.p><p>RESULTSImrecoxib is metabolized by CYP2C9, CYP2D6 and CYP3A4, with the rate of 62.5%, 21.1% and 16.4%, respectively.p><p>CONCLUSIONCYP2C9 is the major enzyme involved in imrecoxib hydroxylation metabolism.p>
Aryl Hydrocarbon Hydroxylases
;
metabolism
;
Cyclooxygenase 2 Inhibitors
;
metabolism
;
Cytochrome P-450 CYP2C9
;
Cytochrome P-450 CYP2D6
;
metabolism
;
Cytochrome P-450 CYP3A
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Hydroxylation
;
Pyrroles
;
metabolism
;
Spectrometry, Mass, Electrospray Ionization
;
Sulfides
;
metabolism
7.In vivo effect of triptolide combined with glycyrrhetinic acid on rat cytochrome P450 enzymes.
Feng-Mei HAN ; Zhi-Hong PENG ; Jun-Jun WANG ; Yong CHEN
Acta Pharmaceutica Sinica 2013;48(7):1136-1141
Triptolide (TP) is a major active component in Tripterygium root, but its therapeutic window was very narrow due to its severe multi-organ toxicity. In this work, the effect of TP combined with glycyrrhetic acid (GA) on mRNA expression and activity of four cytochrome P450 (CYP) enzymes in rat liver was studied after intragastric administration of TP (0.05, 0.3 and 0.6 mg x kg(-1) x day(-1)) and TP (0.6 mg x kg(-1) x day(-1)) combined with GA (30 mg x kg(-1) x day(-1)) for 7 consecutive days. Compared with the control, the high dose of TP significantly up-regulated the mRNA expression levels of CYP2E1, 1A2, 3A1 and 2C11, the co-administration of TP and GA further up-regulated the mRNA expression levels of CYP3A1, 2C11 and 2E1 as compared with the high dose of TP. Meanwhile, TP at high dose and combined with GA significantly increased CYP3A-associated testosterone 6beta-hydroxylation activity (2.2-fold and 4.1-fold, respectively) as compared with the control. Because TP is mainly metabolized by CYP3A2 in male rats, the present work indicated that TP-induced increase of CYP3A activity might be an important reason for the rapidly metabolic clearance of TP in rat liver, and GA can reduce the hepatotoxicity of TP by promoting its hepatic metabolic clearance. Furthermore, the results also suggest that the drug interactions might be occurred when TP and GA were co-administered with other CYP3A substrate drug.
Animals
;
Aryl Hydrocarbon Hydroxylases
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A2
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Cytochrome P450 Family 2
;
Diterpenes
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Dose-Response Relationship, Drug
;
Drug Combinations
;
Drug Interactions
;
Enzyme Activation
;
Epoxy Compounds
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Glycyrrhetinic Acid
;
isolation & purification
;
pharmacology
;
Liver
;
enzymology
;
Male
;
Phenanthrenes
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Plant Roots
;
chemistry
;
Plants, Medicinal
;
chemistry
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Wistar
;
Steroid 16-alpha-Hydroxylase
;
genetics
;
metabolism
;
Tripterygium
;
chemistry
8.In vitro O-demethylation of rotundine by recombinant human CYP isoenzymes.
Chun-zheng LI ; Qing-hui LIN ; Xiao-mei ZHUANG ; Jian-wei XIE ; Hua LI
Acta Pharmaceutica Sinica 2010;45(3):307-313
Rotundine (1 micromol L(-1)) was incubated with a panel of rCYP enzymes (1A2, 2C9, 2C19, 2D6 and 3A4) in vitro. The remained parent drug in incubates was quantitatively analyzed by an Agilent LC-MS. CYP2C19, 3A4 and 2D6 were identified to be the isoenzymes involved in the metabolism of rotundine. The individual contributions of CYP2C19, 3A4 and 2D6 to the rotundine metabolism were assessed using the method of total normalized rate to be 31.46%, 60.37% and 8.17%, respectively. The metabolites of rotundine in incubates were screened with ESI-MS at selected ion mode, and were further identified using MS2 spectra and precise molecular mass obtained from an Agilent LC/Q-TOF-MSMS, as well as MS(n) spectra of LC-iTrap-MS(n). The predominant metabolic pathway of rotundine in rCYP incubates was O-demethylation. A total 5 metabolites were identified including 4 isomerides of mono demethylated rotundine and one di-demethylated metabolite. The results also showed that CYP2C19, 2D6 and 3A4 mediated O-demethylation of methoxyl groups at different positions of rotundine. Furthermore, the ESI-MS cleavage patterns of rotundine and its metabolites were explored by using LC/Q-TOF-MSMS and LC/iTrap-MS(n) techniques.
Analgesics, Non-Narcotic
;
metabolism
;
Aryl Hydrocarbon Hydroxylases
;
metabolism
;
Berberine Alkaloids
;
metabolism
;
Chromatography, Liquid
;
Cytochrome P-450 CYP1A2
;
metabolism
;
Cytochrome P-450 CYP2C19
;
Cytochrome P-450 CYP2C9
;
Cytochrome P-450 CYP2D6
;
metabolism
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Dopamine Antagonists
;
metabolism
;
Humans
;
Isoenzymes
;
metabolism
;
Methylation
;
Recombinant Proteins
;
metabolism
;
Spectrometry, Mass, Electrospray Ionization
9.Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19.
Acta Pharmaceutica Sinica 2007;42(1):8-12
Flavonoids are present in fruits, vegetables and beverages derived from plants, and in many dietary supplements or herbal remedies. A number of naturally occurring flavonoids have been shown to modulate the CYP450 system, including the induction or inhibition of these enzymes. This review focuses on the flavonoid effects on cytochrome P450 (CYP) enzyme CYP1, 2E1, 3A4 and 19. Flavonoids alter CYPs by various mechanisms, including the stimulation of gene expression via specific receptors and/or CYP protein, or mRNA stabilization and so on. But in vivo and in vitro, the effects of flavonoids are not always coincident as a result of concentrations of flavonoids, genetic and environmental factors. As well, flavonoids may interact with drugs through the induction or inhibition of their metabolism. Much attention should be paid to the metabolism interaction of the flavonoids when coadministered with other drugs.
Animals
;
Aromatase
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A1
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1 Inhibitors
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Enzyme Activation
;
drug effects
;
Flavonoids
;
pharmacology
;
Humans
;
RNA, Messenger
;
genetics
;
metabolism
10.Limited Expression of Cytochrome P450 17alpha-Hydroxylase/17,20-Lyase in Prostate Cancer Cell Lines.
Chang Wook JEONG ; Cheol Yong YOON ; Seong Jin JEONG ; Sung Kyu HONG ; Seok Soo BYUN ; Sang Eun LEE
Korean Journal of Urology 2011;52(7):494-497
PURPOSE: Cytochrome P450 17alpha-hydroxylase/17,20-lyase (CYP17A1) is a key enzyme in the androgen biosynthesis pathway. CYP17A1 has been focused on because of the promising results of a potent CYP17A1 inhibitor in the treatment of castration-resistant prostate cancer (CRPC). A hypothesis that intratumoral androgenesis may play a role in the progression of CRPC has recently been postulated. Thus, we evaluated whether commonly used prostate cancer cell lines express CYP17A1. MATERIALS AND METHODS: Androgen-sensitive LNCaP and androgen-insensitive PC-3 and DU145 cells were used. To evaluate the expression of CYP17A1 protein and RNA, we performed Western blotting and RT-PCR, respectively. RESULTS: We were unable to detect either CYP17A1 protein or RNA in any of the cell lines tested. We failed to detect any expression of CYP17A1, despite several repetitions of these techniques under different conditions. CONCLUSIONS: The expression of CYP17A1 protein and RNA in LNCaP, PC-3, and DU145 cells appears to be either absent or too low for detection. The mechanism of action of abiraterone acetate, a CYP17A1 inhibitor, may be related more to adrenal androgen blockade than to intratumoral androgenesis.
Androgens
;
Androstadienes
;
Blotting, Western
;
Cell Line
;
Cytochrome P-450 Enzyme System
;
Cytochromes
;
Prostate
;
Prostatic Neoplasms
;
RNA
;
Steroid 17-alpha-Hydroxylase
;
Abiraterone Acetate